Literature DB >> 20934275

Evaluation of artifacts and distortions of titanium applicators on 3.0-Tesla MRI: feasibility of titanium applicators in MRI-guided brachytherapy for gynecological cancer.

Yusung Kim1, Manickam Muruganandham, Joseph M Modrick, John E Bayouth.   

Abstract

PURPOSE: The aim of this study was to characterize the levels of artifacts and distortions of titanium applicators on 3.0-Tesla magnetic resonance imaging (MRI). METHODS AND MATERIALS: Fletcher-Suit-Delclos-style tandem and ovoids (T&O) and tandem and ring applicator (T&R) were examined. The quality assurance (QA) phantoms for each applicator were designed and filled with copper sulphate solution (1.5 g/l). The artifacts were quantified with the registration of corresponding computed tomography (CT) images. A favorable MR sequence was searched in terms of artifacts. Using the sequence, the artifacts were determined. The geometric distortions induced by the applicators were quantified through each registration of CT and MRI without applicators. The artifacts of T&O were also evaluated on in vivo MRI datasets of 5 patients.
RESULTS: T1-weighted MRI with 1-mm slice thickness was found as a favorable MR sequence. Applying the sequence, the artifacts at the tandem tip of T&O and T&R were determined as 1.5 ± 0.5 mm in a superior direction in phantom studies. In the ovoids of T&O, we found artifacts less than 1.5 ± 0.5 mm. The artifacts of a T&O tandem in vivo were found as less than 2.6 ± 1.3 mm on T1-weighted MRI, whereas less than 6.9 ± 3.4 mm on T2-weighted MRI. No more than 1.2 ± 0.6 mm (3.0 ± 1.5 mm) of distortions, due to a titanium applicator, were measured on T1-weighted MRI (T2-).
CONCLUSION: In 3.0-Tesla MRI, we found the artifact widths at the tip of tandem were less than 1.5 ± 0.5 mm for both T&O and T&R when using T1-weighted MRI in phantom studies. However, exclusive 3.0-Tesla MRI-guided brachytherapy planning with a titanium applicator should be cautiously implemented.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20934275     DOI: 10.1016/j.ijrobp.2010.07.1981

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  21 in total

Review 1.  Review of strategies for MRI based reconstruction of endocavitary and interstitial applicators in brachytherapy of cervical cancer.

Authors:  José Richart; Vicente Carmona-Meseguer; Teresa García-Martínez; Antonio Herreros; Antonio Otal; Santiago Pellejero; Ana Tornero-López; José Pérez-Calatayud
Journal:  Rep Pract Oncol Radiother       Date:  2018-07-23

Review 2.  Magnetic resonance image guided brachytherapy.

Authors:  Kari Tanderup; Akila N Viswanathan; Christian Kirisits; Steven J Frank
Journal:  Semin Radiat Oncol       Date:  2014-07       Impact factor: 5.934

Review 3.  Review of advanced catheter technologies in radiation oncology brachytherapy procedures.

Authors:  Jun Zhou; Leonid Zamdborg; Evelyn Sebastian
Journal:  Cancer Manag Res       Date:  2015-07-16       Impact factor: 3.989

Review 4.  Magnetic resonance imaging-guided brachytherapy for cervical cancer: initiating a program.

Authors:  Amir M Owrangi; Joann I Prisciandaro; Abraam Soliman; Ananth Ravi; William Y Song
Journal:  J Contemp Brachytherapy       Date:  2015-10-30

5.  Improve definition of titanium tandems in MR-guided high dose rate brachytherapy for cervical cancer using proton density weighted MRI.

Authors:  Yanle Hu; Jacqueline Esthappan; Sasa Mutic; Susan Richardson; Hiram A Gay; Julie K Schwarz; Perry W Grigsby
Journal:  Radiat Oncol       Date:  2013-01-17       Impact factor: 3.481

6.  The dosimetric impact of vaginal balloon-packing on intracavitary high-dose-rate brachytherapy for gynecological cancer.

Authors:  William M Rockey; Sudershan K Bhatia; Geraldine M Jacobson; Yusung Kim
Journal:  J Contemp Brachytherapy       Date:  2013-03-29

7.  Decreased cervical cancer cell adhesion on nanotubular titanium for the treatment of cervical cancer.

Authors:  Jara Crear; Kim M Kummer; Thomas J Webster
Journal:  Int J Nanomedicine       Date:  2013-03-06

8.  Dosimetric impact of point A definition on high-dose-rate brachytherapy for cervical cancer: evaluations on conventional point A and MRI-guided, conformal plans.

Authors:  James Anderson; Yunfei Huang; Yusung Kim
Journal:  J Contemp Brachytherapy       Date:  2012-12-28

9.  Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy.

Authors:  Johannes C A Dimopoulos; Peter Petrow; Kari Tanderup; Primoz Petric; Daniel Berger; Christian Kirisits; Erik M Pedersen; Erik van Limbergen; Christine Haie-Meder; Richard Pötter
Journal:  Radiother Oncol       Date:  2012-01-30       Impact factor: 6.280

10.  High resolution (3 Tesla) MRI-guided conformal brachytherapy for cervical cancer: consequences of different high-risk CTV sizes.

Authors:  James W Anderson; Junyi Xia; Ryan T Flynn; Joseph M Modrick; Sudershan K Bhatia; Geraldine M Jacobson; Yusung Kim
Journal:  J Contemp Brachytherapy       Date:  2013-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.